Devonian Health Group Inc.
GSD.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 16.42M | 13.08M | 7.21M | 3.73M | 2.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.42M | 13.08M | 7.21M | 3.73M | 2.38M |
| Cost of Revenue | 11.16M | 8.68M | 4.97M | 2.32M | 1.44M |
| Gross Profit | 5.26M | 4.39M | 2.23M | 1.41M | 936.30K |
| SG&A Expenses | 4.54M | 4.00M | 3.40M | 3.30M | 2.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 89.90K | 89.60K | 89.20K | 88.30K | 87.40K |
| Total Operating Expenses | 16.83M | 13.72M | 9.33M | 6.71M | 5.24M |
| Operating Income | -410.10K | -644.50K | -2.12M | -2.98M | -2.87M |
| Income Before Tax | -647.40K | -913.80K | -2.35M | -3.17M | -3.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.65 | -0.91 | -2.35 | -3.17 | -3.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -647.40K | -913.80K | -2.35M | -3.17M | -3.06M |
| EBIT | -410.10K | -644.50K | -2.12M | -2.98M | -2.87M |
| EBITDA | 44.40K | -176.90K | -1.83M | -2.68M | -2.57M |
| EPS Basic | 0.00 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 589.54M | 587.28M | 586.44M | 571.33M | 557.28M |
| Average Diluted Shares Outstanding | 589.54M | 587.28M | 586.44M | 571.33M | 557.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
